Caroline Helwick[email protected]MRIBreast MRI pinpoints residual disease after chemotherapyBreast MRI accurately reflects the pathologic extent of residual disease following neoadjuvant chemotherapy, and tumor size and contrast kinetics measured by MRI may be useful early predictors of treatment response, according to a study presented at the San Antonio Breast Cancer Symposium.December 18, 2008Page 1 of 1Top StoriesHomeTop World Cup doc in Los Angeles talks radiologyHow is SoFi Stadium managing imaging services during the most-watched single-sport event on the planet?Radiation Oncology/TherapySingle-fraction SBRT a valid option for localized prostate cancerVideosMRI safety topic: metallic cat-eye nail polishMRIMetallic and cat-eye nail polish in MRICTUsing RIS system log data cuts CT scan times, reduces staff overtime
